Comparative Pharmacology
Head-to-head clinical analysis: PHERAZINE W CODEINE versus QOLIANA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHERAZINE W CODEINE versus QOLIANA.
PHERAZINE W/ CODEINE vs QOLIANA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Promethazine is a phenothiazine derivative that acts as a histamine H1 receptor antagonist, antiemetic, and sedative. It also exerts anticholinergic and antidopaminergic effects, particularly at D2 receptors. Codeine is an opioid agonist primarily at mu-opioid receptors, leading to analgesia and antitussive effects. The combination enhances sedation and antiemetic action.
QOLIANA (elagolix) is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist that competitively binds to GnRH receptors in the pituitary gland, thereby reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased ovarian production of estrogen and progesterone, resulting in a hypoestrogenic state.
One tablet (promethazine 6.25 mg / codeine 10 mg) orally every 4-6 hours as needed; maximum 4 tablets in 24 hours.
Initiate at 5 mg orally once daily, increase as tolerated to 10 mg once daily. Maximum dose 20 mg once daily.
None Documented
None Documented
Promethazine: 9-16 hours in adults; codeine: 2.5-3.5 hours; morphine: 1.5-2 hours. Clinical context: The half-life of codeine is shorter, but its active metabolite morphine contributes to analgesia. Accumulation may occur with repeated dosing.
Terminal elimination half-life is 12 hours (range 10–15 hours) in healthy adults; may extend to 18–24 hours in patients with moderate hepatic impairment (Child-Pugh B).
Renal (50-70% as unchanged promethazine and metabolites; codeine and its metabolites, primarily morphine and codeine-6-glucuronide, are excreted renally). Biliary/fecal elimination accounts for less than 10%.
Renal excretion of unchanged drug accounts for approximately 30% of elimination; biliary/fecal excretion accounts for 60% (including metabolites); 10% is metabolized with negligible pulmonary elimination.
Category D/X
Category C
Opioid Agonist
Opioid Agonist